215 related articles for article (PubMed ID: 16146155)
41. Pediatric inflammatory bowel disease: is it different?
Levine A
Dig Dis; 2009; 27(3):212-4. PubMed ID: 19786743
[TBL] [Abstract][Full Text] [Related]
42. Dietary intakes of children with Crohn's disease.
Pons R; Whitten KE; Woodhead H; Leach ST; Lemberg DA; Day AS
Br J Nutr; 2009 Oct; 102(7):1052-7. PubMed ID: 19402936
[TBL] [Abstract][Full Text] [Related]
43. Inflammatory bowel disease in children: a pediatrician's perspective.
Cuffari C
Minerva Pediatr; 2006 Apr; 58(2):139-57. PubMed ID: 16835574
[TBL] [Abstract][Full Text] [Related]
44. Current treatment of inflammatory bowel disease in children.
Markowitz J
Dig Liver Dis; 2008 Jan; 40(1):16-21. PubMed ID: 17988965
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
46. Nutritional Support of Patient with Inflammatory Bowel Disease.
Montgomery SC; Williams CM; Maxwell PJ
Surg Clin North Am; 2015 Dec; 95(6):1271-9, vii. PubMed ID: 26596927
[TBL] [Abstract][Full Text] [Related]
47. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
[TBL] [Abstract][Full Text] [Related]
48. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
[TBL] [Abstract][Full Text] [Related]
49. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology, genes and inflammatory bowel diseases in childhood.
de Mesquita MB; Civitelli F; Levine A
Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
[TBL] [Abstract][Full Text] [Related]
51. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
[TBL] [Abstract][Full Text] [Related]
52. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
53. [Skin manifestations of pediatric inflammatory bowel disease].
Martín de Carpi J; Chávez Caraza K; Vicente Villa MA; González Enseñat MA; Vilar Escrigas P; Vila Miravet V; Guallarte Alias P; Varea Calderón V
An Pediatr (Barc); 2009 Jun; 70(6):570-7. PubMed ID: 19446510
[TBL] [Abstract][Full Text] [Related]
54. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
55. The role of pro-inflammatory cytokines in inflammatory bowel disease growth retardation.
Wong SC; Macrae VE; McGrogan P; Ahmed SF
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):144-55. PubMed ID: 16877976
[TBL] [Abstract][Full Text] [Related]
56. Care that cannot wait: a personal reflection on inflammatory bowel disease.
Shorten A
Aust Nurs J; 1995 May; 2(10):32-4. PubMed ID: 7655632
[No Abstract] [Full Text] [Related]
57. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
58. The expanding universe of inflammatory bowel disease genetics.
Achkar JP; Duerr R
Curr Opin Gastroenterol; 2008 Jul; 24(4):429-34. PubMed ID: 18622155
[TBL] [Abstract][Full Text] [Related]
59. Attitudes toward genetic testing in patients with inflammatory bowel disease.
Lal S; Appelton J; Mascarenhas J; Stempak JM; Esplen MJ; Silverberg MS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):321-7. PubMed ID: 17353697
[TBL] [Abstract][Full Text] [Related]
60. Nutrition in inflammatory bowel disease.
Gassull MA; Cabré E
Curr Opin Clin Nutr Metab Care; 2001 Nov; 4(6):561-9. PubMed ID: 11706295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
